HomeANRO • NYSE
Alto Neuroscience Inc
add
$1.80
2.70%
After Hours:(10.00%)-0.18
$1.62
Closed: Apr 4, 6:06:13 PM UTC-4 · USD · NYSE · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.00M | 44.47% |
Net income | -15.20M | -35.52% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -16.83M | -44.40% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 168.23M | 103.80% |
Total assets | 177.54M | 104.95% |
Total liabilities | 26.08M | 68.59% |
Total equity | 151.46M | — |
Shares outstanding | 27.07M | — |
Price to book | 0.33 | — |
Return on assets | -23.02% | — |
Return on capital | -24.35% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.20M | -35.52% |
Cash from operations | -13.02M | -12.99% |
Cash from investing | -506.00K | -43.75% |
Cash from financing | 49.00K | -99.89% |
Net change in cash | -13.47M | -143.10% |
Free cash flow | -9.52M | 0.75% |
Previous close
$1.85
Day range
$1.60 - $1.82
Year range
$1.60 - $17.55
Market cap
48.73M USD
Avg Volume
372.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
About
Founded
2019
Website
Employees
76
